Heather Gray‐Edwards

2.2k total citations
51 papers, 870 citations indexed

About

Heather Gray‐Edwards is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Heather Gray‐Edwards has authored 51 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Genetics and 21 papers in Physiology. Recurrent topics in Heather Gray‐Edwards's work include Virus-based gene therapy research (24 papers), Lysosomal Storage Disorders Research (20 papers) and RNA Interference and Gene Delivery (9 papers). Heather Gray‐Edwards is often cited by papers focused on Virus-based gene therapy research (24 papers), Lysosomal Storage Disorders Research (20 papers) and RNA Interference and Gene Delivery (9 papers). Heather Gray‐Edwards collaborates with scholars based in United States, France and United Kingdom. Heather Gray‐Edwards's co-authors include Miguel Sena‐Esteves, Douglas R. Martin, Aime K. Johnson, Ashley N. Randle, Victoria J. McCurdy, Nancy R. Cox, Allison M. Bradbury, Neil Aronin, Brandon L. Brunson and Jacob A. Johnson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Heather Gray‐Edwards

49 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather Gray‐Edwards United States 17 540 397 276 129 116 51 870
Allison M. Bradbury United States 19 444 0.8× 323 0.8× 412 1.5× 148 1.1× 86 0.7× 38 875
Juliette Hordeaux United States 13 496 0.9× 514 1.3× 149 0.5× 99 0.8× 138 1.2× 23 842
Michaël Hocquemiller France 12 365 0.7× 268 0.7× 253 0.9× 102 0.8× 83 0.7× 17 642
Jessica Bagel United States 18 435 0.8× 378 1.0× 555 2.0× 192 1.5× 77 0.7× 31 1.0k
Armida Faella United States 10 426 0.8× 332 0.8× 169 0.6× 123 1.0× 122 1.1× 14 793
Todd A. Derksen United States 10 551 1.0× 510 1.3× 213 0.8× 137 1.1× 99 0.9× 10 852
Emily Nurre United States 4 736 1.4× 547 1.4× 135 0.5× 84 0.7× 166 1.4× 5 1.1k
Abdi Ghodsi United States 6 442 0.8× 438 1.1× 172 0.6× 125 1.0× 96 0.8× 6 708
Béatrice Joussemet France 6 413 0.8× 373 0.9× 132 0.5× 84 0.7× 73 0.6× 9 642
Lavanya Bachaboina United States 7 641 1.2× 534 1.3× 77 0.3× 73 0.6× 137 1.2× 9 889

Countries citing papers authored by Heather Gray‐Edwards

Since Specialization
Citations

This map shows the geographic impact of Heather Gray‐Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Gray‐Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Gray‐Edwards more than expected).

Fields of papers citing papers by Heather Gray‐Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Gray‐Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Gray‐Edwards. The network helps show where Heather Gray‐Edwards may publish in the future.

Co-authorship network of co-authors of Heather Gray‐Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Gray‐Edwards. A scholar is included among the top collaborators of Heather Gray‐Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Gray‐Edwards. Heather Gray‐Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnston, Jean M., Precilla D’Souza, Anna Luisa Kühn, et al.. (2025). Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients. Molecular Genetics and Metabolism. 144(3). 109025–109025. 1 indexed citations
2.
Johnston, Jean M., Precilla D’Souza, Anna Luisa Kühn, et al.. (2024). Quantitative reliability assessment of brain MRI volumetric measurements in type II GM1 gangliosidosis patients. SHILAP Revista de lepidopterología. 3. 1410848–1410848. 2 indexed citations
3.
Gray‐Edwards, Heather, et al.. (2024). Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases. Human Gene Therapy. 35(21-22). 886–895. 2 indexed citations
4.
Wang, Feng, Karen Kelly, Pranathi M. Krishnamurthy, et al.. (2024). Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous system. Molecular Therapy. 32(12). 4401–4417. 9 indexed citations
5.
Gray‐Edwards, Heather, et al.. (2023). Precision medicine using whole genome sequencing in a cat identifies a novel COL5A1 variant for classical Ehlers-Danlos syndrome. Journal of Veterinary Internal Medicine. 37(5). 1716–1724. 3 indexed citations
6.
Kell, Pamela, Rohini Sidhu, Mingxing Qian, et al.. (2023). A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis. EBioMedicine. 92. 104627–104627. 8 indexed citations
7.
Corti, Manuela, Barry J. Byrne, Dominic J. Gessler, et al.. (2023). Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation. Molecular Therapy — Methods & Clinical Development. 30. 303–314. 15 indexed citations
8.
Benatti, Hector Ribeiro, Toloo Taghian, Rachael Miller, et al.. (2023). Awake intracerebroventricular delivery and safety assessment of oligonucleotides in a large animal model. Molecular Therapy — Methods & Clinical Development. 31. 101122–101122.
9.
Sena‐Esteves, Miguel, et al.. (2022). Redosing Adeno-Associated Virus Gene Therapy to the Central Nervous System. Human Gene Therapy. 33(17-18). 889–892. 7 indexed citations
10.
Taghian, Toloo, Tim Kuchel, Thomas S. Denney, et al.. (2022). Brain Alterations in Aged OVT73 Sheep Model of Huntington’s Disease: An MRI Based Approach. Journal of Huntington s Disease. 11(4). 391–406. 10 indexed citations
11.
Davidson, Beverly L., Guangping Gao, Elizabeth Berry‐Kravis, et al.. (2022). Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders. Molecular Therapy. 30(7). 2416–2428. 13 indexed citations
12.
Taghian, Toloo, Ana Rita Batista, Michael A. Caldwell, et al.. (2021). Real-time MR tracking of AAV gene therapy with βgal-responsive MR probe in a murine model of GM1-gangliosidosis. Molecular Therapy — Methods & Clinical Development. 23. 128–134. 12 indexed citations
13.
Graff, Emily C., J. Nicholas Cochran, Christopher B. Kaelin, et al.. (2020). PEA15 loss of function and defective cerebral development in the domestic cat. PLoS Genetics. 16(12). e1008671–e1008671. 3 indexed citations
14.
McNulty, Margaret A., Ashley N. Randle, Aime K. Johnson, et al.. (2020). Abnormal epiphyseal development in a feline model of Sandhoff disease. Journal of Orthopaedic Research®. 38(12). 2580–2591. 3 indexed citations
15.
Taghian, Toloo, Mohammed Salman Shazeeb, Jennifer W. Koehler, et al.. (2020). Volume and Infusion Rate Dynamics of Intraparenchymal Central Nervous System Infusion in a Large Animal Model. Human Gene Therapy. 31(11-12). 617–625. 5 indexed citations
16.
McCullagh, Emma, et al.. (2020). Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses. PLoS ONE. 15(12). e0243006–e0243006. 5 indexed citations
17.
Golebiowski, Diane, Toloo Taghian, Paola Rodrı́guez, et al.. (2020). Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice. Molecular Therapy. 28(10). 2150–2160. 15 indexed citations
18.
Gray‐Edwards, Heather. (2017). AAV gene therapy in a Sheep Model of Tay-Sachs disease. 1 indexed citations
19.
Choudhury, Sourav, Damien J. Cabral, Allison M. Keeler, et al.. (2015). Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector. Molecular Therapy. 24(4). 726–735. 91 indexed citations
20.
McCurdy, Victoria J., Hannah E. Rockwell, Allison M. Bradbury, et al.. (2014). Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease. Gene Therapy. 22(2). 181–189. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allison M. Bradbury Breakdown of academic impact, for papers by Juliette Hordeaux Breakdown of academic impact, for papers by Michaël Hocquemiller Breakdown of academic impact, for papers by Jessica Bagel Breakdown of academic impact, for papers by Armida Faella Breakdown of academic impact, for papers by Todd A. Derksen Breakdown of academic impact, for papers by Emily Nurre Breakdown of academic impact, for papers by Abdi Ghodsi Breakdown of academic impact, for papers by Béatrice Joussemet Breakdown of academic impact, for papers by Lavanya Bachaboina
Rankless by CCL
2026